I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 17% ± 2% | |
| natural killer cell | 6 studies | 19% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 28% ± 12% | |
| gamma-delta T cell | 5 studies | 19% ± 5% | |
| CD8-positive, alpha-beta T cell | 4 studies | 18% ± 3% | |
| mucosal invariant T cell | 4 studies | 17% ± 0% | |
| fibroblast | 4 studies | 22% ± 6% | |
| endothelial cell | 4 studies | 23% ± 9% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
| non-classical monocyte | 3 studies | 22% ± 5% | |
| dendritic cell | 3 studies | 24% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 2% |
